MVA Members

Daiichi Sankyo Oncology Nordics ApS

Daiichi Sankyo and its 15,000 employees in more than 20 countries are dedicated to the creation and supply of innovative pharmaceutical products. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, the Group’s 2025 vision is to become a “Global Pharma Innovator with Competitive Advantage in Oncology”. The European headquarters are in Munich, Germany and we have affiliates in 12 European countries.